Amgen Building On Repatha Experience As It Grows In Cardiovascular, Obesity

Execs Shared Strategy At J.P. Morgan Meeting

 
• By Mandy Jackson
  
Amgen has invested millions in physician and patient education already in support of Repatha (Shutterstock)

More from Strategy

More from Market Access